Portfolio concentration
As of January 31, 2026 · N-PORT
Holdings
96
Top-10 weight
40.86%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
35
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
1016.7
Holdings
As of January 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | LILLY ELI and CO | — | 3,696,560 | $3.83B | 9.76% |
| 2 | ASTRAZENECA PLC | — | 11,579,638 | $2.16B | 5.49% |
| 3 | MERCK & CO | — | 18,111,825 | $2.00B | 5.09% |
| 4 | UNITEDHEALTH GRP | — | 4,772,250 | $1.37B | 3.49% |
| 5 | JOHNSON&JOHNSON | — | 5,367,039 | $1.22B | 3.11% |
| 6 | EDWARDS LIFESCIENCES CORP | — | 14,972,830 | $1.22B | 3.10% |
| 7 | GSK PLC | — | 45,301,487 | $1.17B | 2.98% |
| 8 | DANAHER CORP | — | 4,836,473 | $1.06B | 2.70% |
| 9 | ABBOTT LABS | — | 9,253,894 | $1.01B | 2.58% |
| 10 | INTUITIVE SURGICAL INC | — | 1,944,873 | $980.64M | 2.50% |
| 11 | ARGENX SE | — | 1,165,992 | $980.56M | 2.50% |
| 12 | CENCORA INC | — | 2,632,712 | $945.72M | 2.41% |
| 13 | UCB SA | — | 3,023,965 | $921.48M | 2.35% |
| 14 | ABBVIE INC | — | 4,034,908 | $899.82M | 2.29% |
| 15 | MEDTRONIC PLC | — | 8,579,526 | $883.35M | 2.25% |
| 16 | VERTEX PHARMACEUTICALS INC | — | 1,589,663 | $746.98M | 1.90% |
| 17 | CVS HEALTH CORP | — | 9,756,578 | $727.06M | 1.85% |
| 18 | ELEVANCE HEALTH INC | — | 1,879,405 | $649.79M | 1.65% |
| 19 | CARDINAL HEALTH INC | — | 2,840,801 | $610.43M | 1.55% |
| 20 | NOVARTIS AG-REG | — | 3,795,144 | $563.08M | 1.43% |
| 21 | ROCHE HLDG-GENUS | — | 1,206,949 | $548.85M | 1.40% |
| 22 | BIOGEN INC | — | 2,913,639 | $524.13M | 1.33% |
| 23 | GALDERMA GROUP A | — | 2,623,305 | $488.98M | 1.25% |
| 24 | OTSUKA HOLDINGS | — | 7,893,800 | $472.59M | 1.20% |
| 25 | AGILENT TECHNOLOGIES INC | — | 3,480,187 | $465.82M | 1.19% |
| 26 | HCA HEALTHCARE INC | — | 933,410 | $455.76M | 1.16% |
| 27 | CHUGAI PHARMA CO | — | 7,912,642 | $451.98M | 1.15% |
| 28 | ALNYLAM PHARMACEUTICALS INC | — | 1,309,033 | $442.53M | 1.13% |
| 29 | GENMAB AS | — | 1,345,944 | $438.49M | 1.12% |
| 30 | UNITED THERAPEUTICS CORP DEL | — | 892,079 | $418.82M | 1.07% |
| 31 | THERMO FISHER SCIENTIFIC INC | — | 702,318 | $406.37M | 1.03% |
| 32 | BOSTON SCIENTIFIC CORP | — | 4,128,084 | $386.10M | 0.98% |
| 33 | SHIONOGI & CO | — | 18,640,349 | $383.79M | 0.98% |
| 34 | DEXCOM INC | — | 4,655,231 | $340.02M | 0.87% |
| 35 | DAIICHI SANKYO | — | 18,367,566 | $336.49M | 0.86% |
| 36 | IONIS PHARMACEUTICALS INC | — | 3,803,181 | $314.41M | 0.80% |
| 37 | BRISTOL-MYERS SQUIBB CO | — | 5,317,192 | $292.71M | 0.75% |
| 38 | STRYKER CORP | — | 748,338 | $276.56M | 0.70% |
| 39 | QIAGEN NV | — | 5,130,344 | $275.35M | 0.70% |
| 40 | STERIS PLC | — | 1,012,472 | $265.88M | 0.68% |
| 41 | CYTOKINETICS INC | — | 4,050,667 | $255.96M | 0.65% |
| 42 | ASCENDIS PHA-ADR | — | 1,103,469 | $249.49M | 0.64% |
| 43 | STRUCTURE THERAPEUTICS INC DEPOSITARY RECEIPT | — | 2,811,254 | $248.66M | 0.63% |
| 44 | EISAI CO LTD | — | 8,514,317 | $237.37M | 0.60% |
| 45 | REGENERON PHARMACEUTICALS INC | — | 318,062 | $235.83M | 0.60% |
| 46 | REVOLUTION MEDICINES INC | — | 2,383,815 | $231.11M | 0.59% |
| 47 | AVANTOR INC | — | 20,480,758 | $223.65M | 0.57% |
| 48 | ICON PLC | — | 1,213,897 | $218.80M | 0.56% |
| 49 | NOVO NORDISK-B | — | 3,482,834 | $206.81M | 0.53% |
| 50 | MADRIGAL PHARMACEUTICALS INC | — | 398,129 | $194.81M | 0.50% |
1 / 3
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.